Marker Therapeutics, Inc. ( MRKR) - Stock Earnings
MRKR Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -2.0 million USD | 1.2 million USD |
| 2025Q4 | -1.7 million USD | 1.1 million USD |
| 2026Q1 | -3.2 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
MRKR Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -8.2 million USD | 3.3 million USD |
| 2024 | -10.7 million USD | 6.6 million USD |
| 2025 | -12.2 million USD | 3.5 million USD |
| 2026 Est. | — | — |
MRKR
Price: $1.33
52 week price:
Earnings Per Share: -0.55 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 156064
Market Capitalization: 15.3 million